Clinical trial

FujiLAM Prospective Evaluation Trial

NCT04089423

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2019-12-13

PhaseN/A

Study timeline

Study start (actual)2019-12-13Date precision: day

Registry last updated2022-01-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diagnosis of Tuberculosis in People Living With HIVunresolved

Interventions

Fujifilm SILVAMP TB LAMDEVICE

Sponsors & collaborators

Foundation for Innovative New Diagnostics, Switzerlandlead sponsor

Centre for Infectious Disease Research in Zambiacollaborator

Infectious Diseases Institute, Ugandacollaborator

Malawi-Liverpool-Wellcome Trust Clinical Research Programmecollaborator

Swiss Tropical & Public Health Institutecollaborator

Ifakara Health Institutecollaborator

University of Cape Towncollaborator

Viet Tiep Hospitalcollaborator

National Tuberculosis Control Programmecollaborator

Fujifilmcollaborator

Omega Diagnosticscollaborator

Tuberculosis and Lung Disease Hospital in Hai Phongcollaborator

The HIV Netherlands Australia Thailand Research Collaborationcollaborator

Mapped research locations

Cape TownSouth Africa1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04089423 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.